Hospitalization and diabetes mellitus as predictors of unfavorable tuberculosis treatment outcomes.

Saved in:
Bibliographic Details
Title: Hospitalization and diabetes mellitus as predictors of unfavorable tuberculosis treatment outcomes.
Authors: Mendonça EB; Postgraduate Program 'Clinical Research in Infectious Diseases', National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. edson.beyker@ini.fiocruz.br.; Clinical Analysis Laboratory, National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. edson.beyker@ini.fiocruz.br., Araújo-Pereira M; Institute of Clinical and Translational Research, Medicina Zarns, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil., Menezes RC; Institute of Clinical and Translational Research, Medicina Zarns, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil., Vinhaes CLA; Institute of Clinical and Translational Research, Medicina Zarns, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Clinical Research Laboratory on Mycobacteria (LAPCLIN-TB), National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Schmaltz CAS; Clinical Research Laboratory on Mycobacteria (LAPCLIN-TB), National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sant'Anna FM; Clinical Research Laboratory on Mycobacteria (LAPCLIN-TB), National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Ridolfi FM; Clinical Research Laboratory on Mycobacteria (LAPCLIN-TB), National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Andrade BB; Institute of Clinical and Translational Research, Medicina Zarns, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil., Rolla VC; Postgraduate Program 'Clinical Research in Infectious Diseases', National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. valeria.rolla@ini.fiocruz.br.; Clinical Research Laboratory on Mycobacteria (LAPCLIN-TB), National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. valeria.rolla@ini.fiocruz.br.
Source: BMC infectious diseases [BMC Infect Dis] 2026 May 11. Date of Electronic Publication: 2026 May 11.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2334
DOI:10.1186/s12879-026-13343-1